Reference
Lee D, et al. Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland. Applied Health Economics and Health Policy : 16 Jul 2013. Available from: URL: http://dx.doi.org/10.1007/s40258-013-0044-y
Rights and permissions
About this article
Cite this article
Romiplostim dominates current treatment practices in ITP. PharmacoEcon Outcomes News 684, 7 (2013). https://doi.org/10.1007/s40274-013-0609-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0609-x